首页> 外文期刊>Endocrine journal >Autonomic alterations as a clinical manifestation of encephalopathy associated with autoimmune thyroid disease
【24h】

Autonomic alterations as a clinical manifestation of encephalopathy associated with autoimmune thyroid disease

机译:自主性改变是与自身免疫性甲状腺疾病相关的脑病的临床表现

获取原文
       

摘要

Encephalopathy associated with autoimmune thyroid disease (EAATD), also known as Hashimoto’s encephalopathy, is a rare neurological condition that may occur in patients with clinical or sub-clinical autoimmune thyroid disease. The pathogenesis of EAATD has been not clearly elucidated yet. The diagnostic criteria include neurological or psychiatric symptoms, high levels of anti-thyroid antibodies, and exclusion of other possible causes of encephalopathy. In the large majority of cases, EAATD patients respond to immunosuppressant therapies, in particular to corticosteroids. We report the case of a patient with Hashimoto’s thyroiditis and recurrent manifestations of encephalopathy over the previous few years responding to corticosteroid treatment. The patient presented with language and cognitive impairment, ataxia, and neurovegetative/autonomic symptoms. She was euthyroid with mildly raised anti-thyroid peroxidase antibodies. An extensive diagnostic work-up, including electroencephalogram, brain magnetic resonance, hormonal assessment, and an exhaustive panel of antibodies possibly associated with autoimmune encephalopathy, was carried out and excluded other possible etiologies of encephalopathy. The diagnosis of EAATD possibly affecting the hypothalamus and/or the neurovegetative regulatory centers was made and treatment with prednisolone was timely commenced with a dramatic and rapid improvement with progressive normalization of the symptoms. To the best of our knowledge, this is the first report of neurovegetative/autonomic alterations in the setting of EAATD.
机译:与自身免疫性甲状腺疾病(EAATD)相关的脑病,也称为桥本脑病,是一种罕见的神经系统疾病,可能在患有临床或亚临床自身免疫性甲状腺疾病的患者中发生。 EAATD的发病机理尚未明确阐明。诊断标准包括神经或精神症状,高水平的抗甲状腺抗体,以及排除其他可能的脑病原因。在大多数情况下,EAATD患者对免疫抑制剂疗法有反应,尤其是对皮质类固醇激素。我们报道了在过去几年中对皮质类固醇治疗有反应的桥本甲状腺炎和脑病复发表现的患者。患者出现语言和认知障碍,共济失调和神经营养/自主神经症状。她甲状腺功能正常,抗甲状腺过氧化物酶抗体轻度升高。进行了广泛的诊断检查,包括脑电图,脑磁共振,激素评估以及可能与自身免疫性脑病相关的抗体详尽清单,并排除了其他可能的脑病病因。进行了可能影响下丘脑和/或神经营养调节中心的EAATD诊断,并及时开始用泼尼松龙治疗,并随着症状的逐渐正常化而得到了迅速而显着的改善。据我们所知,这是EAATD环境中神经营养/自主神经改变的首次报道。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号